Kondera-Anasz Z, Mertas A
Katedry i Zakladu Immunologii i Serologii Sl. AM, Katowicach.
Pol Tyg Lek. 1993;48(5-6):112-5.
Occurrence and antifibrinogen antibodies level have been determined in sera of 50 individuals with serum sickness and in 50 blood donors constituting the control group. Antifibrinogen antibodies have been detected in blood of 41 (82%) blood recipients. Titre of these antibodies have ranged from 1:8 to 1:512, and their agglutination potency has ranged from 5 to 67 Dunsford's units. Immediately after serum sickness diagnosis a decrease in both level and agglutination potency of these antibodies has been noted. Further treatment with full blood constantly increased both the level and agglutination potency of antifibrinogen antibodies. It is probable, that fibrinogen and its degradation products present in the given blood stimulated antibodies production. This hypothesis is fortified by the observation, that stable decrease in both the level and agglutination potency of antifibrinogen antibodies in patients with serum sickness treated with washed erythrocytes. Antifibrinogen antibodies of a titre ranging from 1:4 to 1:16, and agglutination potency of 5-18 Dunford's units have been detected in 14 blood donors constituting a control group. Specificity of the detected antifibrinogen antibodies as well as their IgG character have been also confirmed.
已对50例血清病患者和50名作为对照组的献血者的血清进行了纤维蛋白原抗体的发生率及水平测定。在41名(82%)受血者的血液中检测到了纤维蛋白原抗体。这些抗体的滴度范围为1:8至1:512,其凝集效价范围为5至67邓斯福德单位。血清病诊断后立即发现这些抗体的水平和凝集效价均下降。用全血进一步治疗持续增加了纤维蛋白原抗体的水平和凝集效价。很可能,给定血液中存在的纤维蛋白原及其降解产物刺激了抗体产生。血清病患者用洗涤红细胞治疗后纤维蛋白原抗体的水平和凝集效价均稳定下降这一观察结果强化了这一假设。在作为对照组的14名献血者中检测到滴度范围为1:4至1:16、凝集效价为5 - 18邓斯福德单位的纤维蛋白原抗体。所检测到的纤维蛋白原抗体的特异性及其IgG特性也得到了证实。